Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;19(11):1172-80.
doi: 10.1002/lt.23724.

Muscle mass predicts outcomes following liver transplantation

Affiliations

Muscle mass predicts outcomes following liver transplantation

Andrea DiMartini et al. Liver Transpl. 2013 Nov.

Abstract

For patients with end-stage liver disease, commonly used indices of nutritional status (ie, body weight and body mass index) are often inflated because of fluid overload (ie, ascites and peripheral edema), and this results in an underdiagnosis of malnutrition. Because muscle is the largest protein reservoir in the body, an estimate of the muscle mass may be a more reliable and valid estimate of nutritional status. Therefore, we used pretransplant computed tomography data for 338 liver transplantation (LT) candidates to identify muscle and fat mass on the basis of a specific abdominal transverse section commonly used in body composition analyses, and we investigated the contribution of this measure to specific post-LT outcomes. We found that the majority of our patients (68%) could be defined as cachectic. For men, muscle mass predicted many important posttransplant outcomes, including intensive care unit (ICU) stay, total length of stay (LOS), and days of intubation. Muscle mass was a significant predictor of survival and also predicted disposition to home versus another facility. For women, muscle mass predicted ICU stay, total LOS, and days of intubation, but the effect was modest. Muscle mass did not predict survival or disposition for women. In conclusion, because pretransplant muscle mass is associated with many important postoperative outcomes, we discuss these findings in the context of possible pretransplant interventions for either improving or sustaining muscle mass before surgery.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript have no conflicts of interest to disclose

Figures

Figure 1
Figure 1
Examples of Body Composition Analysis at L3-4 Transverse Section Legend for Sliceomatic screen images: red is subcutaneous fat, blue is visceral fat and green is muscle. Speckling in the muscle may represent fatty infiltration First Image. 55 yo male ALD, BMI 20, total fat 294, MELD 20, muscle/height 43 (cachetic), LOS 58 days Middle Image. 66 yo male HBV/HCC, BMI 34, total fat 806 MELD 9, muscle/height 56.7 (not cachetic), LOS 26 then to skilled nursing facility, Last Image. 60 yo female with NASH, BMI 30, muscle/height 27.5 (cachetic), total fat 360, MELD 24, died during hospitalization at 21 days
Figure 2
Figure 2
Venn diagram of BMI Classes and Percent Cachetic

Comment in

Similar articles

Cited by

References

    1. Figueiredo FA, Perez RM, Freitas MM, Kondo M. Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis. J of Gastro. 2006;41(5):476–82. - PubMed
    1. Ohkawa S, Odamaki M, Yoneyama T, et al. Standardized thigh muscle area measured by computed axial tomography as an alternate muscle mass index for nutritional assessment of hemodialysis patients. Am J Clin Nutr. 2000;71(2):485–490. - PubMed
    1. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:809–813. - PubMed
    1. Tandon P, Ney M, Irwin I, et al. Severe Muscle Depletion in Patients on the Liver Transplant Wait List: Its Prevalence and Independent Prognostic Value. Liver Transpl. 2012;18:1209–1216. - PubMed
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373–383. - PubMed

Publication types